Tse Hui Lim
Singapore General Hospital(SG)
Publications by Year
Research Areas
Cholangiocarcinoma and Gallbladder Cancer Studies, Genetic factors in colorectal cancer, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Prenatal Screening and Diagnostics
Most-Cited Works
- → Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma(2017)958 cited
- → Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence(2017)156 cited
- → Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis(2019)123 cited
- → Clonal MET Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer(2019)116 cited
- → Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR–CCNB3 gene fusion(2017)75 cited
- → Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer(2016)63 cited
- → Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma(2020)56 cited
- → Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC(2020)53 cited
- → Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast Cancer(2016)53 cited
- → Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia(2005)45 cited